BIOS Health GTM brain

category

market profile

• text: Bioelectronic and drug developers seek to understand neural signals and use biomarkers to guide research and therapy development.
• text: Neural-cardiac therapy development involves collaboration across pharmaceutical R&D, academia and technology organizations.

personas

• title: Pharma neuroscience or cardiovascular R&D leader
  pains:

  • Drug development lacks direct, timely insight into nervous-system response
  • Identifying biomarkers for targeted chronic disease therapies is difficult
• title: Bioelectronic medical device R&D director
  pains:

  • Must interpret complex neural signals and tailor stimulation
  • Needs evidence and collaborators to translate early research into a viable therapy
• title: Translational neuroscience principal investigator
  pains:

  • Neural recording and analysis require specialized hardware and computational skills
  • Connecting neural signals to physiological outcomes across studies is challenging

icp

• text: Pharmaceutical and biotechnology R&D organizations pursuing cardiovascular, autonomic or other chronic disease therapies.
• text: Medical device developers and academic research centers with neural interface or bioelectronic therapy programs; no firm-size threshold disclosed.

message pillars

• text: Read and analyze nervous-system signals in real time.
• text: Use neural biomarkers to inform new treatments.
• text: Personalize neural therapies with recordings and AI.
• text: Develop therapies through long-term partnerships.

objections

• objection: Is this clinically validated for our indication?
  response: Request indication-specific study evidence, intended use and current regulatory status; do not assume a marketed clinical treatment.
• objection: Can neural data fit our existing development program?
  response: Define a joint feasibility study with sample collection, signal quality and biomarker endpoints before committing to a larger collaboration.
• objection: How are commercial rights and timelines structured?
  response: Scope data ownership, intellectual property, milestones and commercialization responsibilities during partnership negotiations.

competitors

• name: Galvani Bioelectronics
  why: Adjacent bioelectronic medicine developer targeting disease through neural modulation.
• name: SetPoint Medical
  why: Develops bioelectronic therapies for chronic disease, competing for development attention and partners.
• name: CorTec
  why: Neural interface and bioelectronic technology provider in the same broad market.

keywords

• neural biomarkers drug discovery
• bioelectronic medicine development
• autonomic nervous system biomarkers
• neural interface AI
• closed loop neuromodulation
• neural dosing platform
• cardiovascular neural therapy

voice

• Visionary and science-led
• Precision medicine focused
• Collaborative

signals

• text: A pharma company launches a bioelectronic or autonomic biomarker program and seeks neural data partners.
• text: A device developer needs neural recordings and analysis for adaptive therapy research.

stack

• NVIDIA GPUs

pricing

motion

channels

• research partnerships
• company blog
• industry press

confidence

Founders

• name: Oliver Armitage
  title: Founder
  role: Founder
• name: Emil Hewage
  title: Founder/Director
  role: Founder